相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adolescent Jump Case in Japan Associated With Influenza but not Oseltamivir
Kihei Terada et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Medical management of influenza infection
Anne Moscona
ANNUAL REVIEW OF MEDICINE (2008)
Pharmacokinetics and tolerability of oseltamivir combined with probenecid
Mark Holodniy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Natalia A. Ilyushina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Current and future antiviral therapy of severe seasonal and avian influenza
John Beigel et al.
ANTIVIRAL RESEARCH (2008)
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes
Yacine Abed et al.
ANTIVIRAL RESEARCH (2008)
Seasonal and pandemic influenza: A 2007 update on challenges and solutions
Arnold S. Monto et al.
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children
Norio Sugaya et al.
CLINICAL INFECTIOUS DISEASES (2008)
Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir A Comprehensive Review
Stephen Toovey et al.
DRUG SAFETY (2008)
Oseltamivir and breastfeeding
Netteke Wentges-van Hothe et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Population pharmacokinetics of oseltamivir when coadministered with probenecid
Craig R. Rayner et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance
Olivier Ferraris et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors
Vanessa Escuret et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan
Y. -M. Chang et al.
JOURNAL OF HOSPITAL INFECTION (2008)
A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B
Naoki Kawai et al.
JOURNAL OF INFECTION (2008)
Influenza virus reactivation after remission with oseltamivir treatment in a patient undergoing nonmyeloablative bone marrow transplantation
Shinichi Kobayashi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2008)
Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model
David A. Boltz et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The course of fever following influenza virus infection in children treated with oseltamivir
Eitaro Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol
Nicole M. Bouvier et al.
JOURNAL OF VIROLOGY (2008)
Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series
I. Nyoman Kandun et al.
LANCET (2008)
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China
Hua Wang et al.
LANCET (2008)
Human infection with highly pathogenic H5N1 influenza virus
Andrea Gambotto et al.
LANCET (2008)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Patrick J. Collins et al.
NATURE (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fatal oseltamivir-resistant influenza virus infection
Erhard van der Vries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza
Walter R. J. Taylor et al.
PLOS ONE (2008)
Antivirals and influenza - Frequency of resistance
Arnold S. Monto
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B
N. J. Welton et al.
STATISTICS IN MEDICINE (2008)
Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata city, Japan
Maki Sato et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Influenza-associated central nervous system dysfunction: A literature review
Stephen Toovey
Travel Medicine and Infectious Disease (2008)
Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
Terry G. Besselaar et al.
EMERGING INFECTIOUS DISEASES (2008)
Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein
Kaori Morimoto et al.
DRUG METABOLISM AND DISPOSITION (2008)
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
Allison McGeer et al.
CLINICAL INFECTIOUS DISEASES (2007)
A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination
Dennis Morrison et al.
PLOS ONE (2007)
The war against influenza: discovery and development of sialidase inhibitors
Mark von Itzstein
NATURE REVIEWS DRUG DISCOVERY (2007)
Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study
William A. Blumentals et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir
Naoki Kawai et al.
JOURNAL OF INFECTION (2007)
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: A retrospective case-control study
Debie Vu et al.
CLINICAL INFECTIOUS DISEASES (2007)
Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects
Jerome J. Schentag et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir
Mariana Baz et al.
ANTIVIRAL RESEARCH (2007)
The critically ill avian influenza A (H5N1) patient
Yaseen Arabi et al.
CRITICAL CARE MEDICINE (2007)
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
Shuji Hatakeyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins
Floyd J. Frost et al.
CHEST (2007)
A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltarnivir
Chuan-Yun Li et al.
CELL RESEARCH (2007)
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus
Elena A. Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes
A. C. Hurt et al.
ANTIVIRAL RESEARCH (2007)
Antiviral effects on influenza viral transmission and pathogenicity: Observations from household-based trials
M. Elizabeth Halloran et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
WHO rapid advice guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
Holger J. Schunemann et al.
LANCET INFECTIOUS DISEASES (2007)
Comparison of the NOW Influenza A & B, NOW Flu A, NOW Flu B, and directigen Flu A+B assays, and immunofluorescence with viral culture for the detection of Influenza A and B viruses
Marita Smit et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an Immunocompromised child
Mariana Baz et al.
CLINICAL INFECTIOUS DISEASES (2006)
Antiviral agents active against influenza A viruses
Erik De Clercq
NATURE REVIEWS DRUG DISCOVERY (2006)
Three Indonesian clusters of H5N1 virus infection in 2005
I. Nyoman Kandun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Avian influenza A (H5N1) infection in eastern Turkey in 2006
Ahmet Faik Oner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
Thomas Zurcher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Pharmacokinetics of oseltamivir in young and very elderly subjects
Masaichi Abe et al.
ANNALS OF PHARMACOTHERAPY (2006)
Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses
Hui-Ling Yen et al.
JOURNAL OF VIROLOGY (2006)
Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases
Niklas Lindegardh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: A Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons
Naoki Kawai et al.
CLINICAL INFECTIOUS DISEASES (2006)
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
Arnold S. Monto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient
AC Hurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Recovery of drug-resistant influenza virus from immunocompromised patients: A case series
MG Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Probenecid with oseltamivir for human influenza A (H5N1) virus infection?
JC Howton
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
RA Bright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Oseltamivir and delirious behavior in children with influenza
A Okumura et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents
Robert Bettis et al.
CLINICAL DRUG INVESTIGATION (2006)
Safety of neuraminidase inhibitors for influenza
Mark Jones et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
RA Bright et al.
LANCET (2005)
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility
HL Yen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice
HL Yen et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Oseltamivir phosphate in infants under 1 year of age with influenza infection
D Tamura et al.
PEDIATRICS INTERNATIONAL (2005)
Experience with oseltamivir for infants younger than 1 year old in Japan
S Okamoto et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate
P Snell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: A multicenter study from Japan of the 2002-2003 influenza season
N Kawai et al.
CLINICAL INFECTIOUS DISEASES (2005)
Brief report: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
P Ward et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations
D Jackson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Human disease from influenza A (H5N1), Thailand, 2004
T Chotpitayasunondh et al.
EMERGING INFECTIOUS DISEASES (2005)
Avian influenza A (H5N1) in 10 patients in Vietnam.
TT Hien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Management of influenza in households: A prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis
FG Hayden et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Resistant influenza A viruses in children treated with oseltarnivir: descriptive study
M Kiso et al.
LANCET (2004)
Detection and control of influenza outbreaks in well-vaccinated nursing home populations
AS Monto et al.
CLINICAL INFECTIOUS DISEASES (2004)
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
LV Gubareva
VIRUS RESEARCH (2004)
Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium
MN Matrosovich et al.
JOURNAL OF VIROLOGY (2004)
Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets
ML Herlocher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations
L Kaiser et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient
DM Weinstock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Early administration of oral oseltamivir increases the benefits of influenza treatment
FY Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Clinical benefits with oseltamivir in treating influenza in adult populations - Results of a pooled and subgroup analysis
S Singh et al.
CLINICAL DRUG INVESTIGATION (2003)
Mechanism by which mutations at His274 alter sensitivity of influenza a virus N1 neuraminidase to oseltamivir carboxylate and zanamivir
MZ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment
A Gillissen et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2002)
A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site
LV Gubareva et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus
TM Tumpey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids
P Snell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
JAL Ives et al.
ANTIVIRAL RESEARCH (2002)
Structural studies of the resistance of influenza virus neuramindase to inhibitors
BJ Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo
J Carr et al.
ANTIVIRAL RESEARCH (2002)
Experience with oseltamivir in the control of nursing home influenza A outbreak
N Shijubo et al.
INTERNAL MEDICINE (2002)
Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000
SK Bowles et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion - Correlation of in vivo and in vitro studies
G Hill et al.
DRUG METABOLISM AND DISPOSITION (2002)
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay
LV Gubareva et al.
ANTIVIRAL RESEARCH (2002)
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
LV Gubareva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population
PH Peters et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
LV Gubareva et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Effectiveness of oseltamivir in preventing influenza in household contacts - A randomized controlled trial
R Welliver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Oral oseltamivir treatment of influenza in children
RJ Whitley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
IA Leneva et al.
ANTIVIRAL RESEARCH (2000)
The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers
JW Massarella et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Resistance of influenza viruses to neuraminidase inhibitors - a review
JL McKimm-Breschkin
ANTIVIRAL RESEARCH (2000)
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
KG Nicholson et al.
LANCET (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
